Health experts said that the controversy over the safety of the emerging coronavirus vaccines will continue to exist, even after the end of clinical trials, and this matter may affect people's confidence in the vaccine and its preventive benefits.
According to the "New York Times" newspaper, millions of people in the United States will receive the Corona vaccine when it is ready, and since many of them will die, due to various factors and diseases, it is likely that death will be linked to the issue of taking the vaccine.
Scientists fear that the death of anyone who took the vaccine will be linked to the issue of complications, while people die from "Covid-19" disease, caused by the Corona virus, and others, and what is meant is that someone, for example, will die due to an old heart disease, but since it is He took the Corona vaccine shortly before in order to protect himself from the virus, his acquaintances and his family may consider the matter to be caused by the vaccine.
The American newspaper reported that this matter requires that federal and state institutions take the initiative to communicate and display data in order to counter misleading campaigns.
The White House initiative is focused, at the present time, on accelerating the development of vaccines against the Corona virus in a record period, through extensive clinical trials, and then passing to manufacturing at a later time.
After starting to use these vaccines, a number of medical and scientific institutions in the United States will continue to monitor the health developments of those who take them.
Researchers from the US Centers for Disease Control and Prevention along with the US Food and Drug Administration (they) have monitored the use of vaccines for decades, and this has helped them develop sophisticated programs for analyzing data.
Researcher Bruce Gillin, president of the Sabin Vaccine Institute, said that following up on developing vaccines is similar to what satellites do in the process of monitoring weather conditions.
But monitoring the hundreds of millions of Americans who will receive vaccines from several companies by next summer will not be easy at all, and it may be a "storm storm" that has not been dealt with before.
In 2009, for example, when a new strain of H1N1 flu spread, researchers quickly developed a vaccine, and between October 2009 and January 2010, it was introduced to more than 82 million people in the United States.
As usual, a special system was formed, at the time, to monitor any worrisome complications for people who had received the vaccine, but in the 1970s, there was an American program that urged parents to report any complications to their children after vaccination.
Since people may report developments unrelated to taking the vaccine, the US health authorities, in the year 1990, relied on a monitoring system that uses the evaluation of health-care-providing agencies in order to notice and report complications when they appear on people who have taken the same vaccine.